Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Herman

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Cureus|December 19, 2023
Flavoring Agents in E-cigarette Liquids: A Comprehensive Analysis of Multiple Health RisksJaspreet Sachdeva, Anisha Karunananthan, Jianru Shi, et al.
Journal of Pharmaceutical Sciences|February 5, 2021
Determination of K869, a Novel Oxime Reactivator of Acetylcholinesterase, in Rat Body Fluids and Tissues by Liquid-Chromatography Methods: Pharmacokinetic StudyNela Vanova, Anna Hojna, Jaroslav Pejchal, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 16, 2020
In vitro and in vivo metabolism of 3-quinuclidinyl benzilate by high-resolution mass spectrometryMartin Uher, Martin Mžik, Jana Žďárová Karasová, et al.
Chemistry & Biology|September 26, 2009
Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencingChunping Xu, Elisabetta Soragni, C James Chou, et al.
Toxicology and Applied Pharmacology|October 21, 2019
Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivatorsVendula Hepnarova, Lubica Muckova, Avi Ring, et al.
American Journal of Ophthalmology|May 31, 2002
Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining visionJessica E Oliver, Matthew G Hattenhauer, David Herman, et al.
Plos One|May 9, 2008
HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse modelMyriam Rai, Elisabetta Soragni, Kai Jenssen, et al.
Molecular and Cellular Biology|February 28, 2002
Promoter scanning for transcription inhibition with DNA-binding polyamidesJennifer A Ehley, Christian Melander, David Herman, et al.
Toxicology Letters|December 4, 2019
Encapsulation of oxime K027 into cucurbit[7]uril: In vivo evaluation of safety, absorption, brain distribution and reactivation effectivenessJana Zdarova Karasova, Vendula Hepnarova, Rudolf Andrys, et al.
Frontiers in Pharmacology|September 27, 2019
The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer's Disease Patients and Its Consequence to Oxidative Stress BiomarkersMartin Valis, David Herman, Nela Vanova, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cureus|December 19, 2023
Flavoring Agents in E-cigarette Liquids: A Comprehensive Analysis of Multiple Health RisksJaspreet Sachdeva, Anisha Karunananthan, Jianru Shi, et al.
Journal of Pharmaceutical Sciences|February 5, 2021
Determination of K869, a Novel Oxime Reactivator of Acetylcholinesterase, in Rat Body Fluids and Tissues by Liquid-Chromatography Methods: Pharmacokinetic StudyNela Vanova, Anna Hojna, Jaroslav Pejchal, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 16, 2020
In vitro and in vivo metabolism of 3-quinuclidinyl benzilate by high-resolution mass spectrometryMartin Uher, Martin Mžik, Jana Žďárová Karasová, et al.
Chemistry & Biology|September 26, 2009
Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencingChunping Xu, Elisabetta Soragni, C James Chou, et al.
Toxicology and Applied Pharmacology|October 21, 2019
Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivatorsVendula Hepnarova, Lubica Muckova, Avi Ring, et al.
American Journal of Ophthalmology|May 31, 2002
Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining visionJessica E Oliver, Matthew G Hattenhauer, David Herman, et al.
Plos One|May 9, 2008
HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse modelMyriam Rai, Elisabetta Soragni, Kai Jenssen, et al.
Molecular and Cellular Biology|February 28, 2002
Promoter scanning for transcription inhibition with DNA-binding polyamidesJennifer A Ehley, Christian Melander, David Herman, et al.
Toxicology Letters|December 4, 2019
Encapsulation of oxime K027 into cucurbit[7]uril: In vivo evaluation of safety, absorption, brain distribution and reactivation effectivenessJana Zdarova Karasova, Vendula Hepnarova, Rudolf Andrys, et al.
Frontiers in Pharmacology|September 27, 2019
The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer's Disease Patients and Its Consequence to Oxidative Stress BiomarkersMartin Valis, David Herman, Nela Vanova, et al.
Pageof 4